Clara Gaff

Clara Gaff

Auto-generated profile, based on publicly available information

Clara Gaff

Department of Paediatrics Melbourne Medical School, University of Melbourne Melbourne Australia

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2017 in JAMA Pediatrics
Verified
Journal Article
Open access
PDF file
TTTiong Yang Tan
Tiong Yang Tan
ODOliver James Dillon
Oliver James Dillon
ZSZornitza Stark
Zornitza Stark
DSDeborah Schofield
Deborah Schofield
KAKhurshid Alam
Khurshid Alam
SWSusan M. White
Susan M. White
Children affected by genetic conditions often have multisystem disease, experience substantial morbidity and mortality, and have higher hospitalization rates with longer admissions compared with the general pediatric population.1-3 The evaluation for a genetic condition in a child, the so-called diagnostic odyssey, typically involves clinical assessment and multiple investigations, many of which are invasive and costly. The diagnostic trajectory can be prolonged, and many children continue to have undiagnosed conditions. Each technological advance in genetic analysis offers an opportunity to improve diagnostic yield, as exemplified by chromosomal microarray over conventional karyotyping,4 but none has the diagnostic power of genomic sequencing. Whole-exome sequencing (WES), the analysis of the protein-coding exons of genes, has the potential to revolutionize the diagnosis in children suspected of having monogenic disorders.5,6 Quiz Ref ID Large-scale studies7-13 of WES in children with broad clinical presentations report diagnostic rates of 25% to 30%, applying WES after multiple genetic investigations, including single-gene or panel testing. Studies using WES as a last resort result in ascertainment bias toward diagnostically difficult cases because children with conditions diagnosed with an earlier gene test would be excluded. The application of WES to a clinically ascertained, sequencing-naive cohort is needed to understand the full impact of WES in the pediatric clinic and to assist clinicians in knowing when and for whom to consider singleton WES.

4 July 2007 in European Journal of Human Genetics
Verified
Journal Article
Open access
PDF file
CGClara L Gaff
Clara L Gaff
ACAngus J Clarke
Angus J Clarke
PAPaul Atkinson
Paul Atkinson
SSStephanie Sivell
Stephanie Sivell
GEGlyn Elwyn
Glyn Elwyn
AEAdrian Edwards
Adrian Edwards
The communication of risk is a central activity in clinical genetics, with genetic health professionals encouraging the dissemination of relevant information by individuals to their at-risk family members. To understand the process by which communication occurs as well as its outcomes, a systematic review of actual communication in families about genetic risk was conducted. Findings from 29 papers meeting the inclusion criteria were summarised and are presented narratively. Family communication about genetic risk is described as a deliberative process, in which: sense is made of personal risk; the vulnerability and receptivity of the family member is assessed; decisions are made about what will be conveyed; and the right time to disclose is selected. The communication strategy adopted will depend on these factors and varies within families as well as between families. Inherent in these processes are conflicting senses of responsibility: to provide potentially valuable information and to prevent harm that may arise from this knowledge. However, the research ‘outcomes’ of communication have been professionally determined (number of relatives reported as informed, uptake of testing, knowledge of the recipient) and are typically unrelated to the concerns of the family member. The impact of communication on the individual, family members, and family relationships is of concern to the individual conveying the information, but this is largely self-reported. Currently, there is insufficient information to inform the development of theoretically and empirically based practice to foster ‘good’ communication. The implications for future research are discussed.

23 June 2010 in European Journal of Human Genetics
Verified
Journal Article
Closed access
NCNicole E Cousens
Nicole E Cousens
CGClara L Gaff
Clara L Gaff
SMSylvia A Metcalfe
Sylvia A Metcalfe
MDMartin B Delatycki
Martin B Delatycki

1 January 2019 in Genetics in Medicine
Verified
Journal Article
Open access
PDF file
ZSZornitza Stark
Zornitza Stark
DSDeborah Schofield
Deborah Schofield
MMMelissa Martyn
Melissa Martyn
LRLuke Rynehart
Luke Rynehart
RSRupendra N. Shrestha
Rupendra N. Shrestha
SWSusan M. White
Susan M. White
To systematically investigate the longer-term clinical and health economic impacts of genomic sequencing for rare-disease diagnoses. We collected information on continuing diagnostic investigation, changes in management, cascade testing, and parental reproductive outcomes in 80 infants who underwent singleton whole-exome sequencing (WES). The median duration of follow-up following result disclosure was 473 days. Changes in clinical management due to diagnostic WES results led to a cost saving of AU$1,578 per quality-adjusted life year gained, without increased hospital service use. Uninformative WES results contributed to the diagnosis of non-Mendelian conditions in seven infants. Further usual diagnostic investigations in those with ongoing suspicion of a genetic condition yielded no new diagnoses, while WES data reanalysis yielded four. Reanalysis at 18 months was more cost-effective than every 6 months. The parents of diagnosed children had eight more ongoing pregnancies than those without a diagnosis. Taking the costs and benefits of cascade testing and reproductive service use into account, there was an additional cost of AU$8,118 per quality-adjusted life year gained due to genomic sequencing. These data strengthen the case for the early use of genomic testing in the diagnostic trajectory, and can guide laboratory policy on periodic WES data reanalysis.

30 October 2007 in Journal of Genetic Counseling
Verified
Journal Article
Closed access
PDF file
SSStephanie Sivell
Stephanie Sivell
GEGlyn Elwyn
Glyn Elwyn
CGClara L. Gaff
Clara L. Gaff
ACAngus J. Clarke
Angus J. Clarke
RIRachel Iredale
Rachel Iredale
AEAdrian Edwards
Adrian Edwards

1 April 2008 in Patient Education and Counseling
Verified
Journal Article
Closed access
AEA. Edwards
A. Edwards
JGJ. Gray
J. Gray
ACA. Clarke
A. Clarke
JDJ. Dundon
J. Dundon
GEG. Elwyn
G. Elwyn
HTH. Thornton
H. Thornton